1. Home
  2. AVDL
  3. AVDL News

Latest Avadel Pharmaceuticals plc (AVDL) News on May 11, 2025

Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results
AVDL

Simply Wall St.

a day ago

Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AVDL

GlobeNewswire

3 days ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
AVDL

Simply Wall St.

3 days ago

Avadel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

AVDL

MT Newswires

3 days ago

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $16 From $13, Maintains Buy Rating

AVDL

GuruFocus.com

3 days ago

Avadel Pharmaceuticals PLC (AVDL) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...

Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight
AVDL

TipRanks

4 days ago

Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight

AVDL

Associated Press Finance

4 days ago

Avadel: Q1 Earnings Snapshot

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance
AVDL

GlobeNewswire

4 days ago

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

AVDL

MT Newswires

5 days ago

Avadel Says Court Grants Favorable Ruling in Appeal of Delaware Injunction on Lumryz

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction
AVDL

GlobeNewswire

5 days ago

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7
AVDL

GlobeNewswire

11 days ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

AVDL

MT Newswires

13 days ago

UBS Adjusts Avadel Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
AVDL

GlobeNewswire

24 days ago

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability
AVDL

Simply Wall St.

a month ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AVDL

GlobeNewswire

a month ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

AVDL

MT Newswires

a month ago

Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference
AVDL

GlobeNewswire

a month ago

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
AVDL

GlobeNewswire

a month ago

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians
AVDL

GlobeNewswire

2 months ago

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 03/10/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 03/07/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 03/06/2025

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AVDL

GlobeNewswire

2 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 03/05/2025

AVDL

MT Newswires

2 months ago

Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 03/04/2025

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
AVDL

Simply Wall St.

2 months ago

Avadel Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

AVDL

GuruFocus.com

2 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

AVDL

Associated Press Finance

2 months ago

Avadel: Q4 Earnings Snapshot

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
AVDL

GlobeNewswire

2 months ago

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 03/03/2025

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?
AVDL

Insider Monkey

2 months ago

Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?

AVDL

GuruFocus.com

2 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Look For

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 02/28/2025

AVDL

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 02/27/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/26/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/25/2025

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
AVDL

GlobeNewswire

3 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
AVDL

GlobeNewswire

3 months ago

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/24/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/21/2025

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AVDL

GlobeNewswire

3 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/20/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/19/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/18/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/14/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/13/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/12/2025

AVDL

MT Newswires

3 months ago

Deutsche Bank Initiates Coverage on Avadel Pharmaceuticals With Buy Rating, $12 Price Target

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/11/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/10/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/07/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/06/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/05/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/04/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 02/03/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 01/31/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 01/30/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 01/29/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 01/28/2025

AVDL

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 01/27/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/24/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 01/23/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/23/2025

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/22/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/21/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/17/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/16/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 01/15/2025

AVDL

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 01/15/2025

AVDL

MT Newswires

4 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $14 From $22, Maintains Buy Rating

AVDL

MT Newswires

4 months ago

Needham Adjusts Avadel Pharmaceuticals' Price Target to $19 From $22, Keeps Buy Rating

AVDL

GuruFocus.com

4 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

AVDL

MT Newswires

4 months ago

Avadel Pharmaceuticals Preliminary Q4 Net Product Revenue Rises; 2025 Outlook Set; Shares Fall After Hours

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
AVDL

GlobeNewswire

4 months ago

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect
AVDL

GuruFocus.com

4 months ago

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AVDL

GlobeNewswire

4 months ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
AVDL

GlobeNewswire

4 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock
AVDL

Simply Wall St.

5 months ago

Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy
AVDL

GlobeNewswire

5 months ago

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

AVDL

MT Newswires

6 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $22 From $25, Maintains Buy Rating

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
AVDL

Simply Wall St.

6 months ago

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
AVDL

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

AVDL

GuruFocus.com

6 months ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...

AVDL

MT Newswires

6 months ago

Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

AVDL

Associated Press Finance

6 months ago

Avadel: Q3 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
AVDL

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings
AVDL

GuruFocus.com

6 months ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12
AVDL

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle
AVDL

Pharmaceutical Technology

6 months ago

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term
AVDL

Simply Wall St.

6 months ago

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation
AVDL

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
AVDL

GlobeNewswire

7 months ago

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

Avadel wins FDA approval for narcolepsy drug Lumryz in children
AVDL

Pharmaceutical Technology

7 months ago

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz
AVDL

Zacks

7 months ago

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz

AVDL

MT Newswires

7 months ago

Avadel Pharmaceuticals Gets FDA Approval for Lumryz to Treat Cataplexy in Narcolepsy Patients

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
AVDL

GlobeNewswire

7 months ago

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

AVDL

GuruFocus.com

7 months ago

Avadel Pharmaceuticals PLC (AVDL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent
AVDL

GlobeNewswire

8 months ago

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

Share on Social Networks: